Kimberly Chong

Array ( [id] => 5194378 [patent_doc_number] => 20070082862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Novel antisense oligonucleotide and anti-hiv agent' [patent_app_type] => utility [patent_app_number] => 10/549601 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6507 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082862.pdf [firstpage_image] =>[orig_patent_app_number] => 10549601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 247213 [patent_doc_number] => 07585967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'Nucleic acid compounds for inhibiting angiogenesis and tumor growth' [patent_app_type] => utility [patent_app_number] => 10/800077 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 129 [patent_no_of_words] => 42268 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585967.pdf [firstpage_image] =>[orig_patent_app_number] => 10800077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834293 [patent_doc_number] => 20060246123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Oligonucleotide mimetics' [patent_app_type] => utility [patent_app_number] => 10/548532 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8912 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246123.pdf [firstpage_image] =>[orig_patent_app_number] => 10548532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672931 [patent_doc_number] => 20040180848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Method of killing cancer cells' [patent_app_type] => new [patent_app_number] => 10/796177 [patent_app_country] => US [patent_app_date] => 2004-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10507 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180848.pdf [firstpage_image] =>[orig_patent_app_number] => 10796177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7155927 [patent_doc_number] => 20050026860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Nucleolin antisense sequence for inhibition of cancer cell proliferation' [patent_app_type] => utility [patent_app_number] => 10/797822 [patent_app_country] => US [patent_app_date] => 2004-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3094 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026860.pdf [firstpage_image] =>[orig_patent_app_number] => 10797822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 132267 [patent_doc_number] => 07700757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Antisense oligonucleotides (ODN) against Smad7 and uses in medical field thereof' [patent_app_type] => utility [patent_app_number] => 10/551643 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 8857 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700757.pdf [firstpage_image] =>[orig_patent_app_number] => 10551643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7456150 [patent_doc_number] => 20040197235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Methods and apparatus for determining analytes in various matrices' [patent_app_type] => new [patent_app_number] => 10/789864 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18649 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197235.pdf [firstpage_image] =>[orig_patent_app_number] => 10789864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468156 [patent_doc_number] => 20040167091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Methods for treating ocular neovascular diseases' [patent_app_type] => new [patent_app_number] => 10/786491 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11928 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167091.pdf [firstpage_image] =>[orig_patent_app_number] => 10786491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918723 [patent_doc_number] => 20050096284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/783128 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 74477 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096284.pdf [firstpage_image] =>[orig_patent_app_number] => 10783128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468153 [patent_doc_number] => 20040167090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Covalent modification of RNA for in vitro and in vivo delivery' [patent_app_type] => new [patent_app_number] => 10/782075 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16315 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167090.pdf [firstpage_image] =>[orig_patent_app_number] => 10782075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112211 [patent_doc_number] => 07713738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Oligomeric compounds for the modulation of survivin expression' [patent_app_type] => utility [patent_app_number] => 10/776934 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 50792 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713738.pdf [firstpage_image] =>[orig_patent_app_number] => 10776934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7456920 [patent_doc_number] => 20040197316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Novel method for the treatment of systemic lupus erythematosus' [patent_app_type] => new [patent_app_number] => 10/772704 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13048 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197316.pdf [firstpage_image] =>[orig_patent_app_number] => 10772704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7238433 [patent_doc_number] => 20040157790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Process for delivering sirna to cardiac muscle tissue' [patent_app_type] => new [patent_app_number] => 10/770588 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8986 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157790.pdf [firstpage_image] =>[orig_patent_app_number] => 10770588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 236405 [patent_doc_number] => 07595386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-29 [patent_title] => 'Methods and compositions for heat activated gene therapy using cytolethal distending toxin' [patent_app_type] => utility [patent_app_number] => 10/764316 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6691 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/595/07595386.pdf [firstpage_image] =>[orig_patent_app_number] => 10764316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7377607 [patent_doc_number] => 20040220082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Manipulation of neuronal ion channels' [patent_app_type] => new [patent_app_number] => 10/761557 [patent_app_country] => US [patent_app_date] => 2004-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26234 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220082.pdf [firstpage_image] =>[orig_patent_app_number] => 10761557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672969 [patent_doc_number] => 20060178324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Lipophilic derivatives of double-stranded ribonucleic acid' [patent_app_type] => utility [patent_app_number] => 10/543048 [patent_app_country] => US [patent_app_date] => 2004-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17290 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178324.pdf [firstpage_image] =>[orig_patent_app_number] => 10543048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341745 [patent_doc_number] => 07501503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Compositions and methods for inhibiting RNase H activity of retroid reverse transcriptase' [patent_app_type] => utility [patent_app_number] => 10/748475 [patent_app_country] => US [patent_app_date] => 2003-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11984 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501503.pdf [firstpage_image] =>[orig_patent_app_number] => 10748475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4705123 [patent_doc_number] => 20080064647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Prna Chimera' [patent_app_type] => utility [patent_app_number] => 10/539241 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 21969 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064647.pdf [firstpage_image] =>[orig_patent_app_number] => 10539241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7263915 [patent_doc_number] => 20040241854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'siRNA-mediated gene silencing' [patent_app_type] => new [patent_app_number] => 10/738642 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 38364 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241854.pdf [firstpage_image] =>[orig_patent_app_number] => 10738642 [rel_patent_id] =>[rel_patent_doc_number] =>)